SCHEMBL6891746

SCHEMBL6891746

CCC(C)(C)NCc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.50
CYP2D6 P10635 2/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 4/20 0.46
CYP3A4 P08684 3/20 0.46
KDM4E B2RXH2 2/20 0.46
IDO1 P14902 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
THRB P10828 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
TP53 P04637 1/20 0.42
ATM Q13315 1/20 0.41
HTT P42858 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ALDH1A1 P00352 1/20 0.40
SLC6A2 P23975 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20163215 0.98 RIPK1 (0.49) RIPK1CYP2D6LMNAMAPTCYP3A4
SCHEMBL11751773 0.84 CYP2D6 (0.48) RIPK1CYP2D6LMNAMAPTCYP3A4
SCHEMBL19963515 0.84 CYP2D6 (0.48) RIPK1CYP2D6LMNAMAPTCYP3A4
SCHEMBL21790795 0.83 CYP2D6 (0.44) RIPK1CYP2D6LMNAMAPTCYP3A4
SCHEMBL11818840 0.83 LMNA (0.63) RIPK1CYP2D6LMNAMAPTCYP3A4
SCHEMBL20686991 0.83 RIPK1 (0.50) RIPK1CYP2D6LMNAMAPTCYP3A4
SCHEMBL11526495 0.82 RIPK1 (0.46) RIPK1CYP2D6LMNAMAPTCYP3A4
SCHEMBL4984383 0.81 CYP2D6 (0.45) RIPK1CYP2D6LMNAMAPTCYP3A4
SCHEMBL21104761 0.81 HPGD (0.53) MAPTKDM4EIDO1MEN1KMT2A
SCHEMBL6098836 0.81 CYP3A4 (0.46) RIPK1CYP2D6LMNAMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10865163-B2 Carbon dioxide as a directing group for C—H functionalization reactions involving Lewis basic amines, alcohols, thiols, and phosphines for the synthesis of compounds THE UNIVERSITY OF TOLEDO (US) 2020-12-15 US claimed
EP-3081283-B1 METHOD FOR REMOVING SOX IN GAS BY USING ETHYLENE GLYCOL COMPLEX SOLUTION BEIJING BOYUAN HENGSHENG HIGH TECH CO LTD (CN) 2020-10-21 EP claimed
US-20190185392-A1 Carbon Dioxide as a Directing Group for C-H Functionalization Reactions Involving Lewis Basic Amines, Alcohols, Thiols, and Phosphines for the Synthesis of Compounds THE UNIVERSITY OF TOLEDO (US) 2019-06-20 US claimed
EP-0972333-B1 METHODS AND SYSTEMS FOR ENHANCED FLUID TRANSPORT CALIPER LIFE SCIENCES INC (US) 2004-11-24 EP claimed
US-20220127613-A1 Functionally-Modified Oligonucleotides And Subunits Thereof SAREPTA THERAPEUTICS INC (US) 2022-04-28 US disclosed
US-11208655-B2 Functionally-modified oligonucleotides and subunits thereof SAREPTA THERAPEUTICS, INC. (US) 2021-12-28 US disclosed
EP-3059004-B1 METHOD FOR REMOVING SOX FROM GAS WITH COMPLEX ALCOHOL-AMINE SOLUTION BEIJING BOYUAN HENGSHENG HIGH TECH CO LTD (CN) 2021-06-30 EP disclosed
US-20210070703-A1 SULFAMOYLBENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION UNIV DREXEL (US) 2021-03-11 US disclosed
EP-3090797-B1 METHOD FOR REMOVING SOX FROM GAS USING A POLYOL COMPLEX SOLUTION BEIJING BOYUAN HENGSHENG HIGH TECH CO LTD (CN) 2021-01-20 EP disclosed
US-10865163-B2 Carbon dioxide as a directing group for C—H functionalization reactions involving Lewis basic amines, alcohols, thiols, and phosphines for the synthesis of compounds THE UNIVERSITY OF TOLEDO (US) 2020-12-15 US disclosed
US-10865163-B2 Carbon dioxide as a directing group for C—H functionalization reactions involving Lewis basic amines, alcohols, thiols, and phosphines for the synthesis of compounds THE UNIVERSITY OF TOLEDO (US) 2020-12-15 US disclosed
EP-3081283-B1 METHOD FOR REMOVING SOX IN GAS BY USING ETHYLENE GLYCOL COMPLEX SOLUTION BEIJING BOYUAN HENGSHENG HIGH TECH CO LTD (CN) 2020-10-21 EP disclosed
US-20170021304-A1 Method for Removing SOx from Gas Using Ethylene Glycol Composite Solution PEKING UNIVERSITY (CN) 2017-01-26 US disclosed
EP-3090797-A1 METHOD FOR REMOVING SOX FROM GAS USING POLYOL COMPLEX SOLUTION& xA; Beijing Boyuan-Hengsheng High-Technology Co., Ltd. (CN) 2016-11-09 EP disclosed
US-20160310888-A1 Method for Removing SOx from Gas Using Polyol Composite Solution YONGFENG BOYUAN INDUSTRY CO. LTD., JIANGXI PROVINCE (CN) 2016-10-27 US disclosed
EP-3081283-A1 METHOD FOR REMOVING SOX IN GAS BY USING ETHYLENE GLYCOL COMPLEX SOLUTION Beijing Boyuan-Hengsheng High-Technology Co., Ltd. (CN) 2016-10-19 EP disclosed
US-20160243491-A1 Method for Removing SOx from Gas with Compound Alcohol-Amine Solution PEKING UNIVERSITY (CN) 2016-08-25 US disclosed
EP-3059004-A1 METHOD FOR REMOVING SOX FROM GAS WITHNCOMPOUND ALCOHOL-AMINE SOLUTION Beijing Boyuan-Hengsheng High-Technology Co., Ltd. (CN) 2016-08-24 EP disclosed
CN-1051702-C Preparing process of amine derivative and fungusicide containing amine derivative SCIENT RESEARCH AND PHARMACEUT (JP) 2000-04-26 CN disclosed
CN-1035771-A Process for the preparation of amine derivatives and fungicides containing amine derivatives SCIENT RESEARCH AND PHARMACEUT (JP) 1989-09-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190185392-A1 Carbon Dioxide as a Directing Group for C-H Functionalization Reactions Involving Lewis Basic Amines, Alcohols, Thiols, and Phosphines for the Synthesis of Compounds CHKB, HRH3, PNMT RIPK1 3270/4885CYP2D6 3428/4885LMNA 3235/4885
US-11208655-B2 Functionally-modified oligonucleotides and subunits thereof RTCB, NSUN3, NSUN2 RIPK1 3568/4885CYP2D6 4218/4885LMNA 2334/4885
US-20210070703-A1 SULFAMOYLBENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION ALKBH5, SULT1A1, SHMT1 RIPK1 4469/4885CYP2D6 436/4885LMNA 2634/4885
US-10865163-B2 Carbon dioxide as a directing group for C—H functionalization reactions involving Lewis basic amines, alcohols, thiols, and phosphines for the synthesis of compounds CHKB, HRH3, PNMT RIPK1 3358/4885CYP2D6 3403/4885LMNA 3249/4885
US-20220127613-A1 Functionally-Modified Oligonucleotides And Subunits Thereof RTCB, NSUN3, NSUN2 RIPK1 3568/4885CYP2D6 4218/4885LMNA 2334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.